Carregant...
Fitxers
Tipus de document
ArticleVersió
Versió publicadaData de publicació
Llicència de publicació
Si us plau utilitzeu sempre aquest identificador per citar o enllaçar aquest document: https://hdl.handle.net/2445/104407
Type 2 diabetes, antidiabetic medications, and colorectal cancer risk: two case-control studies from Italy and Spain
Títol de la revista
Director/Tutor
ISSN de la revista
Títol del volum
Recurs relacionat
Resum
Background: type 2 diabetes mellitus has been associated with an excess risk of colorectal cancer, although the time-risk relationship is unclear, and there is limited information on the role of antidiabetic medications. Aim: we examined the association between type 2 diabetes, antidiabetic medications, and the risk of colorectal cancer, considering also duration of exposures. Methods: we analyzed data derived from two companion case-control studies conducted in Italy and Spain between 2007 and 2013 on 1,147 histologically confirmed colorectal cancer cases and 1,594 corresponding controls. Odds ratios (ORs) and 95% confidence intervals (CIs) were estimated by unconditional multiple logistic regression models, adjusted for socioeconomic factors and major potential confounding factors. Results: overall, 14% of cases and 12% of controls reported a diagnosis of diabetes, corresponding to an OR of colorectal cancer of 1.21 (95% CI 0.95-1.55). The OR was 1.49 (95% CI 0.97-2.29) for a duration of diabetes of at least 15 years. The OR was 1.53 (95% CI 1.06-2.19) for proximal colon cancer, 0.94 (95% CI 0.66-1.36) for distal colon cancer, and 1.32 (95% CI 0.94-1.87) for rectal cancer. In comparison with no use, metformin use was associated with a decreased colorectal cancer risk (OR 0.47, 95% CI 0.24-0.92), while insulin use was associated with an increased risk (OR 2.20, 95% CI 1.12-4.33); these associations were stronger for longer use (OR 0.36 and 8.18 for ≥10 years of use of metformin and insulin, respectively). Conclusion: this study shows evidence of a positive association between diabetes and colorectal cancer, mainly proximal colon cancer. Moreover, it indicates a negative association between colorectal cancer and metformin use and a positive association for insulin use.
Matèries (anglès)
Citació
Citació
ROSATO, Valentina, TAVANI, Alessandra, GRACIA LAVEDAN, Esther, GUINÓ, Elisabet, CASTAÑO-VINYALS, Gemma, VILLANUEVA, Cristina m., KOGEVINAS, Manolis, POLESEL, Jerry, SERRAINO, Diego, PISA, Federica e., BARBONE, Fabio, MORENO AGUADO, Víctor, LA VECCHIA, Carlo, BOSETTI, Cristina. Type 2 diabetes, antidiabetic medications, and colorectal cancer risk: two case-control studies from Italy and Spain. _Frontiers in Oncology_. 2016. Vol. 6, núm. 210. [consulta: 14 de gener de 2026]. ISSN: 2234-943X. [Disponible a: https://hdl.handle.net/2445/104407]